Zelgen Pharmaceutical ZGGS15 bispecific antibody received FDA clinical trial approval
On June 8, 2023, Zelgen Pharma announced that its investigational product ZGGS15 (LAG-3/TIGIT) bispecific antibody clinical trial application has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced solid tumors. According to the public information query, ZGGS15 is the world's first anti-LAG-3 /TIGIT bispecific antibody approved and is about to enter clinical trials.
Previously, on April 24, 2023, Zelgen Pharma announced that the clinical trial of ZGGS15 for injection in the treatment of advanced solid tumors had been approved by the National Food and Drug Administration (NMPA). ZGGS15 for injection has been approved for clinical trials in China and the United States at the same time. Zelgen Pharmaceutical will actively promote the clinical research of this product.
You May Interested In
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
$161 million! China Biopharmaceutical completes acquisition of F-star Therapeutics
-
European Petrochemical Weakness Leaves Naphtha Oversupplied as Cracker Demand Struggles
-
BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion
-
Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6
-
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
Two Saudi Crude Supertankers Hit in Hormuz as Brent Surges to Nearly $95
-
UAE Withdraws from OPEC
-
Middle East Conflict Hits the Electronics Supply Chain as PPE Resin Shortage Sends PCB Prices Up 40%
-
Butadiene Rubber's Cost in China Floor Collapses, Exports Hold the Line
Recommend Reading
-
![Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages]()
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
-
![EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food]()
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
![Indonesia’s Plastic Prices Jump 50%–100% as Government Moves to Remove Import Duties]()
Indonesia’s Plastic Prices Jump 50%–100% as Government Moves to Remove Import Duties
-
![India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence]()
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
![EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040]()
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
![Maleic Anhydride Continues to Decline in September, But May See an Upward Trend in October]()
Maleic Anhydride Continues to Decline in September, But May See an Upward Trend in October
-
![Expected Minor Fluctuations in Lithium Carbonate Prices in October]()
Expected Minor Fluctuations in Lithium Carbonate Prices in October
-
![Business Society: Formic Acid Price Center Moves Lower, Entering a Consolidation Phase]()
Business Society: Formic Acid Price Center Moves Lower, Entering a Consolidation Phase
-
![China's Marine Fuel Market Sees Volatile Rise in September]()
China's Marine Fuel Market Sees Volatile Rise in September
-
![Sodium Hypochlorite: Uses, Concentration Guide, and Critical Safety Hazards]()
Sodium Hypochlorite: Uses, Concentration Guide, and Critical Safety Hazards
